Anika Therapeutics Inc. - stock earnings

ANIK Quarterly earnings

DateEarningsRevenue
2023Q4 -63.0 million USD 43.0 million USD
2023Q3 -6.6 million USD 41.5 million USD
2023Q2 -2.7 million USD 44.3 million USD
2023Q1 -10.4 million USD 37.9 million USD
2022Q4 -4.9 million USD 39.6 million USD
2022Q3 -4.2 million USD 40.3 million USD
2022Q2 -2.8 million USD 39.7 million USD
2022Q1 -2.9 million USD 36.7 million USD
2021Q4 -5.8 million USD 35.8 million USD
2021Q3 558000 USD 39.5 million USD
2021Q2 6.5 million USD 38.1 million USD
2021Q1 2.8 million USD 34.3 million USD
2020Q4 -15.7 million USD 32.7 million USD
2020Q3 -6.4 million USD 31.7 million USD
2020Q2 -7.7 million USD 30.7 million USD
2020Q1 3.5 million USD 35.4 million USD
2019Q4 4.1 million USD 29.8 million USD
2019Q3 9.2 million USD 29.7 million USD
2019Q2 9.4 million USD 30.4 million USD
2019Q1 4.5 million USD 24.7 million USD
2018Q4 7.7 million USD 27.0 million USD
2018Q3 7.6 million USD 26.8 million USD
2018Q2 10.1 million USD 30.5 million USD
2018Q1 -6.7 million USD 21.3 million USD
2017Q4 8.1 million USD 29.4 million USD
2017Q3 6.9 million USD 27.2 million USD
2017Q2 11.4 million USD 33.5 million USD
2017Q1 5.5 million USD 23.4 million USD
2016Q4 8.1 million USD 28.7 million USD
2016Q3 9.0 million USD 25.8 million USD
2016Q2 8.6 million USD 26.6 million USD
2016Q1 6.9 million USD 22.3 million USD
2015Q4 11.0 million USD 30.9 million USD
2015Q3 8.4 million USD 23.7 million USD
2015Q2 7.8 million USD 22.9 million USD
2015Q1 3.5 million USD 15.5 million USD
2014Q4 7.8 million USD 23.3 million USD
2014Q3 6.2 million USD 22.1 million USD
2014Q2 9.3 million USD 26.3 million USD
2014Q1 15.0 million USD 34.0 million USD
2013Q4 6.7 million USD 21.3 million USD
2013Q3 5.0 million USD 17.8 million USD
2013Q2 5.9 million USD 20.8 million USD
2013Q1 3.1 million USD 15.2 million USD
2012Q4 4.5 million USD 22.6 million USD
2012Q3 1.6 million USD 14.8 million USD
2012Q2 3.7 million USD 19.6 million USD
2012Q1 1.9 million USD 14.4 million USD
2011Q4 2.9 million USD 18.4 million USD
2011Q3 3.0 million USD 18.5 million USD
2011Q2 2.3 million USD 16.1 million USD
2011Q1 324412 USD 11.7 million USD
2010Q4 1.4 million USD 14.7 million USD
2010Q3 1.2 million USD 13.9 million USD
2010Q2 1.1 million USD 14.5 million USD
2010Q1 714280 USD 12.5 million USD
2009Q4 697148 USD 10.6 million USD
2009Q3 1.5 million USD 10.8 million USD
2009Q2 955774 USD 9.5 million USD
2009Q1 522720 USD 9.2 million USD
2008Q4 1.1 million USD 9.0 million USD
2008Q3 1.1 million USD 9.2 million USD
2008Q2 812929 USD 9.1 million USD
2008Q1 617558 USD 8.5 million USD
2007Q4 1.7 million USD 9.6 million USD
2007Q3 1.8 million USD 8.0 million USD
2007Q2 1.4 million USD 7.1 million USD
2007Q1 1.2 million USD 6.1 million USD
2006Q4 1.0 million USD 5.9 million USD
2006Q3 1.3 million USD 6.2 million USD
2006Q2 1.4 million USD 7.8 million USD
2006Q1 880749 USD 7.0 million USD
2005Q4 822000 USD 5.5 million USD
2005Q3 2.5 million USD 10.1 million USD
2005Q2 1.3 million USD 7.0 million USD
2005Q1 1.2 million USD 7.3 million USD
2004Q4 1.8 million USD 7.7 million USD
2004Q3 884000 USD 6.4 million USD
2004Q2 765000 USD 6.3 million USD
2004Q1 7.8 million USD 6.1 million USD
2003Q4 801000 USD 5.0 million USD
2003Q3 420000 USD 3.7 million USD
2003Q2 -81000 USD 3.3 million USD
2003Q1 -313000 USD 3.4 million USD
2002Q4 659082 USD 4.1 million USD
2002Q3 -737643 USD 3.2 million USD
2002Q2 -1.2 million USD 3.4 million USD
2002Q1 -1.8 million USD 2.4 million USD
2001Q4 -456757 USD 3.2 million USD
2001Q3 -1.3 million USD 3.1 million USD
2001Q2 -2.7 million USD 2.9 million USD
2001Q1 2.3 million USD 7.1 million USD
2000Q4 2.3 million USD 7.1 million USD
2000Q3 -1.4 million USD 2.7 million USD
2000Q2 -218489 USD 3.8 million USD
2000Q1 -564087 USD 2.7 million USD
1999Q4 -3.3 million USD 3.0 million USD
1999Q3 ? USD 3.5 million USD
1999Q2 400000 USD 3.8 million USD
1999Q1 300000 USD 3.2 million USD
1998Q4 700000 USD 3.4 million USD
1998Q3 700000 USD 3.2 million USD
1998Q2 2.2 million USD 4.6 million USD
1998Q1 600000 USD 2.8 million USD
1997Q4 3.0 million USD 6.0 million USD
1997Q3 -300000 USD 1.6 million USD
1997Q2 300000 USD 2.5 million USD
1997Q1 200000 USD 1.9 million USD
1996Q4 -900000 USD 1.1 million USD
1996Q3 -900000 USD 1.1 million USD
1996Q2 -600000 USD 1.5 million USD
1996Q1 -600000 USD 1.5 million USD
1995Q4 -900000 USD 1.0 million USD
1995Q3 -500000 USD 900000 USD
1995Q2 -900000 USD 900000 USD
1995Q1 -500000 USD 900000 USD
1994Q4 -200000 USD 700000 USD
1994Q3 -400000 USD 900000 USD
1994Q2 -500000 USD 1.1 million USD
1994Q1 -500000 USD 1.0 million USD
1993Q4 -200000 USD 1.4 million USD
1993Q3 -100000 USD 1.2 million USD
1993Q2 -500000 USD 2.1 million USD
1993Q1 -400000 USD 100000 USD

ANIK Yearly earnings

DateEarningsRevenue
2023 -82.7 million USD 166.7 million USD
2022 -14.9 million USD 156.2 million USD
2021 4.1 million USD 147.8 million USD
2020 -24.0 million USD 130.5 million USD
2019 27.2 million USD 114.6 million USD
2018 18.7 million USD 105.6 million USD
2017 31.8 million USD 113.4 million USD
2016 32.5 million USD 103.4 million USD
2015 30.8 million USD 93.0 million USD
2014 38.3 million USD 105.6 million USD
2013 20.6 million USD 75.1 million USD
2012 11.8 million USD 71.4 million USD
2011 8.5 million USD 64.8 million USD
2010 4.3 million USD 55.6 million USD
2009 3.7 million USD 40.1 million USD
2008 3.6 million USD 35.8 million USD
2007 6.0 million USD 30.8 million USD
2006 4.6 million USD 26.8 million USD
2005 5.9 million USD 29.8 million USD
2004 11.2 million USD 26.5 million USD
2003 827000 USD 15.4 million USD
2002 -3.0 million USD 13.2 million USD
2001 -6.8 million USD 11.3 million USD
2000 173554 USD 16.3 million USD
1999 -2.5 million USD 13.5 million USD
1998 4.3 million USD 13.9 million USD
1997 3.3 million USD 12.0 million USD
1996 -2.7 million USD 1.2 million USD
1995 -2.0 million USD 3.4 million USD
1994 -1.4 million USD 4.7 million USD
1993 -1.6 million USD 2.2 million USD

ANIK

Price: $27.59

52 week price:
16.54
28.87

Payout Ratio Range:
26.42%
71.19%

Earnings Per Share: -5.64 USD

P/E Ratio: -14.19

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 53407

Ebitda: 11.5 million

Market Capitalization: 384.0 million

Links: